Allele summation of diabetes risk genes predicts impaired glucose tolerance in female and obese individuals

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Linder, Katarzyna ^a   Wagner, Robert ^a   Hatziagelaki, Erifili ^b   Ketterer, Caroline ^a   Heni, Martin ^a   Machicao, Fausto ^a   Stefan, Norbert ^a   Staiger, Harald ^a   Häring, Hans Ulrich ^a   Fritsche, Andreas ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POTASSIUM CHANNEL KCNQ1; TRANSCRIPTION FACTOR 7 LIKE 2;

ADULT; ALLELE; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; ETHNIC GROUP; FEMALE; FTO GENE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LOAD; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HEALTH HAZARD; HHEX GENE; HUMAN; IMPAIRED FASTING GLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; KCNJ11 GENE; KCNQ1 GENE; MAJOR CLINICAL STUDY; MALE; MTNR1B GENE; OBESITY; POPULATION RESEARCH; PPARG GENE; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC30A8 GENE; TCF7L2 GENE; WFS1 GENE;

ADULT; ALLELES; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; OBESITY; ODDS RATIO; RISK FACTORS;

EID: 84863100135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038224     Document Type: Article

References (37)

1. Ershow A, (2009) Environmental influences on development of type 2 diabetes and obesity: challenges in personalizing prevention and management. Journal of diabetes science and technology 3: 727-734.
2. Staiger H, Machicao F, Fritsche A, Haring H-U, (2009) Pathomechanisms of Type 2 Diabetes Genes. Endocr Rev 30: 557-585.
3. Doria A, Patti M-E, Kahn CR, (2008) The emerging genetic architecture of type 2 diabetes. Cell Metab 8: 186-200 doi:10.1016/j.cmet.2008.08.006.
4. McCarthy MI, (2010) Genomics, Type 2 Diabetes, and Obesity. N Engl J Med 363: 2339-2350 doi:10.1056/NEJMra0906948.
5. Billings L, Florez J, (2010) The genetics of type 2 diabetes: what have we learned from GWAS? Annals of the New York Academy of Sciences 1212: 59-77.
6. Tabák A, Jokela M, Akbaraly T, Brunner E, Kivimäki M, et al. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373: 2215-2221.
7. Weir GC, Bonner-Weir S, (2004) Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53: S16-21.
8. DeFronzo RA, Abdul-Ghani M, (2011) Type 2 diabetes can be prevented with early pharmacological intervention. Diabetes Care 34: S202-209 doi:10.2337/dc11-s221.
9. DECODE Study Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26: 688-696.
10. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, et al. (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur. Heart J 28: 88-136 doi:10.1093/eurheartj/ehl260.
11. Ford ES, Zhao G, Li C, (2010) Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J. Am. Coll. Cardiol 55: 1310-1317 doi:10.1016/j.jacc.2009.10.060.
12. Lango H, Palmer CNA, Morris AD, Zeggini E, Hattersley AT, et al. (2008) Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 57: 3129-3135 doi:10.2337/db08-0504.
13. Reiling E, van 't Riet E, Groenewoud MJ, Welschen LMC, van Hove EC, et al. (2009) Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk. Diabetologia 52: 1866-1870 doi:10.1007/s00125-009-1413-9.
14. Heni M, Ketterer C, Thamer C, Herzberg-Schäfer SA, Guthoff M, et al. (2010) Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion. Diabetes 59: 3247-3252 doi:10.2337/db10-0674.
15. Kirchhoff K, Machicao F, Haupt A, Schäfer S, Tschritter O, et al. (2008) Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 51: 597-601.
16. Staiger H, Stancáková A, Zilinskaite J, Vänttinen M, Hansen T, et al. (2008) A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study. Diabetes 57: 514-517 doi:10.2337/db07-1254.
17. Schäfer SA, Müssig K, Staiger H, Machicao F, Stefan N, et al. (2009) A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion. Diabetologia 52: 1075-1082 doi:10.1007/s00125-009-1344-5.
18. Müssig K, Staiger H, Machicao F, Kirchhoff K, Guthoff M, et al. (2009) Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion. Diabetes 58: 1715-1720 doi:10.2337/db08-1589.
19. Staiger H, Machicao F, Schäfer SA, Kirchhoff K, Kantartzis K, et al. (2008) Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS ONE 3: e3962 doi:10.1371/journal.pone.0003962.
20. Haupt A, Thamer C, Staiger H, Tschritter O, Kirchhoff K, et al. (2009) Variation in the FTO gene influences food intake but not energy expenditure. Exp. Clin. Endocrinol. Diabetes 117: 194-197 doi:10.1055/s-0028-1087176.
21. Alberti KG, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med 15: 539-553. doi:10.1002/(SICI)1096-9136(199807)15:7&539::AID-DIA668>3.0.CO;2-S.
22. Matsuda M, DeFronzo RA, (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
23. Hivert M-F, Jablonski KA, Perreault L, Saxena R, McAteer JB, et al. (2011) Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 60: 1340-1348 doi:10.2337/db10-1119.
24. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, et al. (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N. Engl. J. Med 359: 2208-2219 doi:10.1056/NEJMoa0804742.
25. Faul F, Erdfelder E, Buchner A, Lang A-G, (2009) Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41: 1149-1160 doi:10.3758/BRM.41.4.1149.
26. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, et al. (2001) What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J. Clin. Endocrinol. Metab 86: 1020-1025.
27. Sims EA, (2001) Are there persons who are obese, but metabolically healthy? Metab. Clin. Exp 50: 1499-1504 doi:10.1053/meta.2001.27213.
28. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, et al. (2008) Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168: 1609-1616 doi:10.1001/archinte.168.15.1609.
29. Cauchi S, Nead KT, Choquet H, Horber F, Potoczna N, et al. (2008) The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med. Genet 9: 45 doi:10.1186/1471-2350-9-45.
30. Haupt A, Guthoff M, Schäfer SA, Kirchhoff K, Machicao F, et al. (2009) The inhibitory effect of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity. J. Clin. Endocrinol. Metab 94: 1775-1780 doi:10.1210/jc.2008-1876.
31. Cornelis MC, Qi L, Zhang C, Kraft P, Manson J, et al. (2009) Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Ann. Intern. Med 150: 541-550.
32. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, et al. (2010) Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42: 949-960 doi:10.1038/ng.685.
33. Mykkänen L, Laakso M, Uusitupa M, Pyörälä K, (1990) Prevalence of Diabetes and Impaired Glucose Tolerance in Elderly Subjects and Their Association With Obesity and Family History of Diabete. Diabetes care 13: 1099-1105.
34. Ding EL, Song Y, Malik VS, Liu S, (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295: 1288-1299 doi:10.1001/jama.295.11.1288.
35. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, et al. (2009) Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N. Engl. J. Med. 361: 1152-1163 doi:10.1056/NEJMoa0804381.
36. Peter A, Kantartzis K, Machann J, Schick F, Staiger H, et al. (2010) Relationships of Circulating Sex Hormone-Binding Globulin With Metabolic Traits in Humans. Diabetes 59: 3167-3173 doi:10.2337/db10-0179.
37. Perry JRB, Weedon MN, Langenberg C, Jackson AU, Lyssenko V, et al. (2010) Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum. Mol. Genet. 19: 535-544 doi:10.1093/hmg/ddp522.